本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Alpha Tau Medical

3.93
+0.15003.97%
盘后3.930.00000.00%16:00 EDT
成交量:2.11万
成交额:8.15万
市值:3.34亿
市盈率:-8.12
高:4.25
开:3.80
低:3.79
收:3.78
52周最高:4.69
52周最低:2.12
股本:8,504.32万
流通股本:5,713.21万
量比:0.28
换手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):-0.4839
每股收益(LYR):-0.4540
净资产收益率:-43.83%
总资产收益率:-22.66%
市净率:3.86
市盈率(LYR):-8.66

数据加载中...

2025/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

SEC问询函

Form CORRESP - Correspondence
2025/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC问询函

Form CORRESP - Correspondence
2023/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/23

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC问询函

CORRESP [Cover] - Correspondence